XOMA Corp. | Mutual Funds
Mutual Funds that own XOMA Corp.
Vanguard Total Stock Market Index Fund
192,716
2.29%
0
0%
07/31/2018
iShares Russell 2000 ETF
119,585
1.43%
-63
0.01%
09/06/2018
FCP OP Medical BioHe@lth-Trends
119,259
1.42%
-10,900
1.27%
11/30/2017
Vanguard Extended Market Index Fund
82,588
0.99%
0
0%
07/31/2018
APO Medical Opportunities
81,223
0.97%
4,869
0.28%
03/31/2018
Delaware Healthcare Fund
46,410
0.55%
6,410
0.13%
03/31/2018
APO Medical Opportunities Institutionell
42,517
0.51%
3,300
0.4%
06/29/2018
Fidelity Spartan Extended Market Index Fund
33,875
0.4%
0
0%
07/31/2018
iShares Russell 2000 Value ETF
29,416
0.35%
0
0.01%
09/06/2018
iShares Russell 2000 Growth ETF
28,155
0.34%
0
0.01%
09/06/2018
| Address |
2200 Powell Street
Emeryville California 94608
United States
|
|
Employees
|
- |
| Website |
http://www.xoma.com |
| Updated |
07/08/2019 |
| XOMA Corp. engages in the discovery and development of innovative therapeutics derived from unique platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. |
